In-Vivo Biodistribution and Safety of (99m)Tc-LLP2A-HYNIC in Canine Non-Hodgkin Lymphoma

Theranostic agents are critical for improving the diagnosis and treatment of non-Hodgkin Lymphoma (NHL). The peptidomimetic LLP2A is a novel peptide receptor radiotherapy candidate for treating NHL that expresses the activated α4β1 integrin. Tumor-bearing dogs are an excellent model of human NHL wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwingenberger, Allison L., Kent, Michael S., Liu, Ruiwu, Kukis, David L., Wisner, Erik R., DeNardo, Sally J., Taylor, Sandra L., Chen, Xiucui, Lam, Kit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335845/
https://www.ncbi.nlm.nih.gov/pubmed/22545083
http://dx.doi.org/10.1371/journal.pone.0034404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335845/
https://www.ncbi.nlm.nih.gov/pubmed/22545083
http://dx.doi.org/10.1371/journal.pone.0034404

Ejemplares similares